Physician profile
Noel Lopez
NPI 1831119908
$13,464.88
in general payments reported to CMS, 2019-2025
56 companies · $1,507 in 2025
The $1,507 reported for 2025 was more than what 92% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,464 · 2020: $1,983 · 2021: $2,138 · 2022: $2,643 · 2023: $2,373 · 2024: $1,357 · 2025: $1,507.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,160 · Education: $76.49.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,160.06 |
| Education | $76.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,160.59 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Abbvie INC. | $925.10 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $895.67 | 2019-2025 | Farxiga, Breztri, Airsupra |
| Sanofi-Aventis U.S. LLC | $840.06 | 2019-2023 | |
| Inspire Medical Systems, INC. | $803.71 | 2023-2025 | Inspire |
| Lilly USA, LLC | $743.89 | 2019-2025 | Mounjaro, Trulicity, Jardiance |
| Amgen INC. | $581.33 | 2019-2023 | Repatha, Otezla, Evenity |
| Boehringer Ingelheim Pharmaceuticals, INC. | $526.58 | 2019-2025 | Jardiance |
| Pfizer INC. | $511.98 | 2019-2024 | |
| Glaxosmithkline, LLC. | $492.37 | 2019-2025 | Trelegy Ellipta, Shingrix |
| Corcept Therapeutics | $407.02 | 2021-2025 | Korlym |
| Janssen Pharmaceuticals, INC | $400.34 | 2019-2024 | Xarelto |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $393.76 | 2019-2025 | Xifaxan, Trulance |
| Insulet Corporation | $372.74 | 2019-2025 | Omnipod |
| Abbott Laboratories | $335.48 | 2022-2025 | Freestyle Libre |
Show all 56 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $311.47 | 2020-2025 | Austedo Xr, Austedo Xr, Austedo |
| Merck Sharp & Dohme LLC | $299.32 | 2020-2023 | Belsomra, Steglatro |
| Ironwood Pharmaceuticals, INC | $298.77 | 2020-2024 | Linzess |
| Gm Pharmaceuticals, INC. | $280.69 | 2020 | |
| Amarin Pharma, INC. | $234.93 | 2019-2020 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $234.26 | 2020-2025 | Caplyta |
| Takeda Pharmaceuticals U.S.A., INC. | $229.83 | 2019-2023 | Trintellix |
| Daiichi Sankyo INC. | $181.20 | 2022-2025 | Injectafer |
| Kowa Pharmaceuticals America, INC. | $168.93 | 2020-2023 | Seglentis, Livalo |
| Baxter Healthcare | $168.00 | 2022 | |
| Exact Sciences Corporation | $160.69 | 2023-2025 | Cologuard Collection Kit |
| Astellas Pharma US INC | $159.39 | 2022-2024 | Veozah |
| Dexcom, INC. | $156.06 | 2021-2025 | Dexcom G6 Transmitter |
| Mannkind Corporation | $148.80 | 2019-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $142.65 | 2021 | |
| Allergan, INC. | $117.28 | 2019-2021 | |
| Arbor Pharmaceuticals, INC. | $95.94 | 2020-2021 | |
| Biohaven Pharmaceuticals, INC. | $82.14 | 2020-2021 | |
| Seqirus USA INC | $71.23 | 2025 | Flucelvax, Fluad |
| Biohaven Pharmaceutical Holding Company LTD. | $65.18 | 2022 | |
| Esperion Therapeutics, INC. | $52.24 | 2021-2023 | Nexletol |
| Genentech USA, INC. | $42.50 | 2020-2021 | |
| Avanir Pharmaceuticals, INC. | $39.54 | 2019-2020 | |
| Optinose US, INC. | $35.18 | 2021-2023 | |
| Phadia US INC. | $31.94 | 2021-2025 | Immunocap |
| Xeris Pharmaceuticals, INC. | $27.17 | 2022 | |
| Horizon Therapeutics Plc | $26.40 | 2019-2021 | |
| Alk-Abello, INC | $24.41 | 2025 | Grastek, Odactra, Ragwitek |
| Otsuka America Pharmaceutical, INC. | $19.33 | 2024 | Rexulti |
| Radius Health, INC. | $18.20 | 2020 | |
| Urgo Medical North America, LLC | $17.10 | 2024 | Urgok2, Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap, Drawtex Hydroconductive Wound Dressing With Levafiber 4x4 |
| Nestle Healthcare Nutrition INC. | $16.98 | 2022 | |
| Sumitomo Pharma America, INC. | $16.14 | 2024 | Gemtesa |
| Ultragenyx Pharmaceutical INC. | $15.47 | 2023 | |
| Paratek Pharmaceuticals, INC. | $14.42 | 2021 | |
| Shire North American Group INC | $14.29 | 2019 | |
| Si-Bone, INC. | $13.39 | 2020 | |
| Eisai INC. | $12.21 | 2021 | |
| Novartis Pharmaceuticals Corporation | $11.91 | 2021 | |
| Ironshore Pharmaceuticals INC. | $11.09 | 2019 | |
| Phathom Pharmaceuticals, INC. | $7.59 | 2025 | Voquezna |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Noel Lopez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.